A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens

Molecular Immunology

Volumn 46, Issue 11-12, 2009, Pages 2210-2217

  Wu, Qunfeng ^a   Fang, Liurong ^a   Wu, Xuebao ^a   Li, Bin ^a   Luo, Rui ^a   Yu, Zhengjun ^a   Jin, Meilin ^a   Chen, Huanchun ^a   Xiao, Shaobo ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

H5N1 avian influenza virus; Hemagglutinin protein; Pseudotype baculovirus; Vaccine

Indexed keywords

ANTIBODY; BACULOVIRUS VECTOR; DNA VACCINE; GAMMA INTERFERON; HEMAGGLUTININ; INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; CELLULAR IMMUNITY; CHICKEN; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE; INFLUENZA VIRUS A H5N1; LD 50; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; VACCINATION; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BACULOVIRIDAE; CELL LINE; CHICKENS; CRICETINAE; DOGS; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, ACTIVE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MICE; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, DNA; VESICULOVIRUS;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS; MAMMALIA; MUS; ORTHOMYXOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 67349281969     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.04.017     Document Type: Article

References (30)

1. Abe T., Hemmi H., Miyamoto H., Moriishi K., Tamura S., Takaku H., Akira S., and Matsuura Y. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J. Virol. 79 (2005) 2847-2858
2. Bai B., Lu X., Meng J., Hu Q., Mao P., Lu B., Chen Z., Yuan Z., and Wang H. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol. Immunol. 45 (2008) 868-875
3. Barsoum J., Brown R., McKee M., and Boyce F.M. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene. Ther. 8 (1997) 2011-2018
4. Bright R.A., Carter D.M., Crevar C.J., Toapanta F.R., Steckbeck J.D., Cole K.S., Kumar N.M., Pushko P., Smith G., Tumpey T.M., and Ross T.M. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS. ONE 3 (2008) e1501
5. Chen M.W., Cheng T.J., Huang Y., Jan J.T., Ma S.H., Yu A.L., Wong C.H., and Ho D.D. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 13538-13543
6. DiNapoli J.M., Yang L., Suguitan Jr. A., Elankumaran S., Dorward D.W., Murphy B.R., Samal S.K., Collins P.L., and Bukreyev A. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J. Virol. 81 (2007) 11560-11568
7. Doherty P.C., Turner S.J., Webby R.G., and Thomas P.G. Influenza and the challenge for immunology. Nat. Immunol. 7 (2006) 449-455
8. Facciabene A., Aurisicchio L., and La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J. Virol. 78 (2004) 8663-8672
9. Fan H., Pan Y., Fang L., Wang D., Wang S., Jiang Y., Chen H., and Xiao S. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J. Virol. Methods 150 (2008) 21-26
10. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., Robbins P.D., Swayne D.E., Donis R.O., Katz J.M., Barratt-Boyes S.M., and Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80 (2006) 1959-1964
11. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S., Jiang Y., Yang C., Yu K., Bu Z., and Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 81 (2007) 150-158
12. Hervas-Stubbs S., Rueda P., Lopez L., and Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 178 (2007) 2361-2369
13. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., and Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10099-10103
14. Holman D.H., Wang D., Raja N.U., Luo M., Moore K.M., Woraratanadharm J., Mytle N., and Dong J.Y. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 26 (2008) 2627-2639
15. Hu Y.C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta. Pharmacol. Sinica 26 (2005) 405-416
16. James C.M., Foong Y.Y., Mansfield J.P., Vind A.R., Fenwick S.G., and Ellis T.M. Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine 26 (2008) 5345-5351
17. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., Li Y., Wang X., Ge J., Bu Z., and Chen H. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res. 75 (2007) 234-241
18. Kost T.A., Condreay J.P., and Jarvis D. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23 (2005) 567-575
19. Kreijtz J.H., Suezer Y., van Amerongen G., de Mutsert G., Schnierle B.S., Wood J.M., Kuiken T., Fouchier R.A., Lower J., Osterhaus A.D., Sutter G., and Rimmelzwaan G.F. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J. Infect. Dis. 195 (2007) 1598-1606
20. Lalor P.A., Webby R.J., Morrow J., Rusalov D., Kaslow D.C., Rolland A., and Smith L.R. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J. Infect. Dis. 197 (2008) 1643-1652
21. Lu L., Yu L., and Kwang J. Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem. Biophys. Res. Commun. 358 (2007) 404-409
22. Martyn J.C., Dong X., Holmes-Brown S., Pribul P., Li S., Drummer H.E., and Gowans E.J. Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus. Arch. Virol. 152 (2007) 329-343
23. McMurry J.A., Johansson B.E., and De Groot A.S. A call to cellular and humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum. Vaccin. 4 (2008) 148-157
24. Murakami S., Iwasa A., Iwatsuki-Horimoto K., Ito M., Kiso M., Kida H., Takada A., Nidom C.A., Mai L.Q., Yamada S., Imai H., Sakai-Tagawa Y., Kawaoka Y., and Horimoto T. Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model. Vaccine 26 (2008) 6398-63404
25. Pieroni L., Maione D., and La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum. Gene. Ther. 12 (2001) 871-881
26. Strauss R., Huser A., Ni S., Tuve S., Kiviat N., Sow P.S., Hofmann C., and Lieber A. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein. Mol. Ther. 15 (2007) 193-202
27. Subbarao K., and Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat. Rev. Immunol. 7 (2007) 267-278
28. Tani H., Limn C.K., Yap C.C., Onishi M., Nozaki M., Nishimune Y., Okahashi N., Kitagawa Y., Watanabe R., Mochizuki R., Moriishi K., and Matsuura Y. In vitro and in vivo gene delivery by recombinant baculoviruses. J. Virol. 77 (2003) 9799-9808
29. Wang S., Fang L., Fan H., Jiang Y., Pan Y., Luo R., Zhao Q., Chen H., and Xiao S. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 25 (2007) 8220-8227
30. Webster R.G., Peiris M., Chen H., and Guan Y. H5N1 outbreaks and enzootic influenza. Emerg. Infect. Dis. 12 (2006) 3-8